BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21221749)

  • 1. Clinical and host genetic characteristics of Mendelian susceptibility to mycobacterial diseases in Japan.
    Hoshina T; Takada H; Sasaki-Mihara Y; Kusuhara K; Ohshima K; Okada S; Kobayashi M; Ohara O; Hara T
    J Clin Immunol; 2011 Jun; 31(3):309-14. PubMed ID: 21221749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical and Genetic Features of 32 Iranian Patients.
    Mahdaviani SA; Mansouri D; Jamee M; Zaki-Dizaji M; Aghdam KR; Mortaz E; Khorasanizadeh M; Eskian M; Movahedi M; Ghaffaripour H; Baghaie N; Hassanzad M; Chavoshzadeh Z; Mansouri M; Mesdaghi M; Ghaini M; Noori F; Eskandarzadeh S; Kahkooi S; Poorabdolah M; Tabarsi P; Moniri A; Farnia P; Karimi A; Boisson-Dupuis S; Rezaei N; Marjani M; Casanova JL; Bustamante J; Velayati AA
    J Clin Immunol; 2020 Aug; 40(6):872-882. PubMed ID: 32602053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe disseminated mycobacterial infection in a boy with a novel mutation leading to IFN-γR2 deficiency.
    Kilic SS; van Wengen A; de Paus RA; Celebi S; Meziane B; Hafizoglu D; van Dissel JT; van de Vosse E
    J Infect; 2012 Dec; 65(6):568-72. PubMed ID: 22902943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Status of the Management of Mendelian Susceptibility to Mycobacterial Disease in Mainland China.
    Ying W; Liu D; Dong X; Wang W; Hui X; Hou J; Yao H; Zhou Q; Sun B; Sun J; Wang X
    J Clin Immunol; 2019 Aug; 39(6):600-610. PubMed ID: 31367980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of interleukin-12 receptor β1 and interferon gamma receptor 1 deficiency in patients with disseminated BCG infection.
    Pourakbari B; Hosseinpour Sadeghi R; Mahmoudi S; Parvaneh N; Keshavarz Valian S; Mamishi S
    Allergol Immunopathol (Madr); 2019; 47(1):38-42. PubMed ID: 30268380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases.
    Al-Muhsen S; Casanova JL
    J Allergy Clin Immunol; 2008 Dec; 122(6):1043-51; quiz 1052-3. PubMed ID: 19084105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular immunity to mycobacteria: knowledge from the mutation and phenotype spectrum analysis of Mendelian susceptibility to mycobacterial diseases.
    Qu HQ; Fisher-Hoch SP; McCormick JB
    Int J Infect Dis; 2011 May; 15(5):e305-13. PubMed ID: 21330176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunological profile of children with Mendelian Susceptibility to Mycobacterial Diseases (MSMD) from an Indian tertiary care hospital.
    Indumathi CK; Bustamante J
    Indian J Tuberc; 2021 Apr; 68(2):292-297. PubMed ID: 33845970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited disorders of IL-12- and IFNgamma-mediated immunity: a molecular genetics update.
    Döffinger R; Dupuis S; Picard C; Fieschi C; Feinberg J; Barcenas-Morales G; Casanova JL
    Mol Immunol; 2002 May; 38(12-13):903-9. PubMed ID: 12009568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic heterogeneity of Mendelian susceptibility to mycobacterial infection.
    Döffinger R; Altare F; Casanova JL
    Microbes Infect; 2000 Nov; 2(13):1553-7. PubMed ID: 11113374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood.
    Remus N; Reichenbach J; Picard C; Rietschel C; Wood P; Lammas D; Kumararatne DS; Casanova JL
    Pediatr Res; 2001 Jul; 50(1):8-13. PubMed ID: 11420412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease.
    Kong XF; Vogt G; Itan Y; Macura-Biegun A; Szaflarska A; Kowalczyk D; Chapgier A; Abhyankar A; Furthner D; Djambas Khayat C; Okada S; Bryant VL; Bogunovic D; Kreins A; Moncada-Vélez M; Migaud M; Al-Ajaji S; Al-Muhsen S; Holland SM; Abel L; Picard C; Chaussabel D; Bustamante J; Casanova JL; Boisson-Dupuis S
    Hum Mol Genet; 2013 Feb; 22(4):769-81. PubMed ID: 23161749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Molecular Findings in Mendelian Susceptibility to Mycobacterial Diseases: Experience From India.
    Taur PD; Gowri V; Pandrowala AA; Iyengar VV; Chougule A; Golwala Z; Chandak S; Agarwal R; Keni P; Dighe N; Bodhanwala M; Prabhu S; George B; Fouzia NA; Edison ES; Arunachalam AK; Madkaikar MR; Dalvi AD; Yadav RM; Bargir UA; Kambli PM; Rawat A; Das J; Joshi V; Pilania RK; Jindal AK; Bhat S; Bhattad S; Unni J; Radhakrishnan N; Raj R; Uppuluri R; Patel S; Lashkari HP; Aggarwal A; Kalra M; Udwadia Z; Bafna VS; Kanade T; Puel A; Bustamante J; Casanova JL; Desai MM
    Front Immunol; 2021; 12():631298. PubMed ID: 33732252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced osteoclastogenesis in patients with MSMD due to impaired response to IFN-γ.
    Tsumura M; Miki M; Mizoguchi Y; Hirata O; Nishimura S; Tamaura M; Kagawa R; Hayakawa S; Kobayashi M; Okada S
    J Allergy Clin Immunol; 2022 Jan; 149(1):252-261.e6. PubMed ID: 34176646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production.
    Filipe-Santos O; Bustamante J; Haverkamp MH; Vinolo E; Ku CL; Puel A; Frucht DM; Christel K; von Bernuth H; Jouanguy E; Feinberg J; Durandy A; Senechal B; Chapgier A; Vogt G; de Beaucoudrey L; Fieschi C; Picard C; Garfa M; Chemli J; Bejaoui M; Tsolia MN; Kutukculer N; Plebani A; Notarangelo L; Bodemer C; Geissmann F; Israël A; Véron M; Knackstedt M; Barbouche R; Abel L; Magdorf K; Gendrel D; Agou F; Holland SM; Casanova JL
    J Exp Med; 2006 Jul; 203(7):1745-59. PubMed ID: 16818673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited human IFN-γ deficiency underlies mycobacterial disease.
    Kerner G; Rosain J; Guérin A; Al-Khabaz A; Oleaga-Quintas C; Rapaport F; Massaad MJ; Ding JY; Khan T; Ali FA; Rahman M; Deswarte C; Martinez-Barricarte R; Geha RS; Jeanne-Julien V; Garcia D; Chi CY; Yang R; Roynard M; Fleckenstein B; Rozenberg F; Boisson-Dupuis S; Ku CL; Seeleuthner Y; Béziat V; Marr N; Abel L; Al-Herz W; Casanova JL; Bustamante J
    J Clin Invest; 2020 Jun; 130(6):3158-3171. PubMed ID: 32163377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three novel compound heterozygous IL12RB1 mutations in Chinese patients with Mendelian susceptibility to mycobacterial disease.
    Zhou X; Jia W; Ni Z; Wang A; Liu Z; Hou M; Zhou M; Tang Z; Zhang D; Li L; Han T; Tan Y; Luo G; Wang J; Wu Y; Zhang X
    PLoS One; 2019; 14(4):e0215648. PubMed ID: 30998751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mendelian Susceptibility to Mycobacterial Disease: Retrospective Clinical and Genetic Study in Mexico.
    Peñafiel Vicuña AK; Yamazaki Nakashimada M; León Lara X; Mendieta Flores E; Nuñez Núñez ME; Lona-Reyes JC; Hernández Nieto L; Ramírez Vázquez MG; Barroso Santos J; López Iñiguez Á; González Y; Torres M; Lezana Fernández JL; Román Montes CM; Medina-Torres EA; González Serrano E; Bustamante Ogando JC; Lugo Reyes S; Zavaleta Martínez O; Staines Boone AT; Venegas Montoya E; Aguilar Gómez NE; Soudeé C; Jouanguy E; Puel A; Boisson-Dupuis S; Pedraza Sánchez S; Casanova JL; Espinosa Rosales F; Espinosa Padilla S; Bustamante J; Blancas Galicia L
    J Clin Immunol; 2023 Jan; 43(1):123-135. PubMed ID: 36044171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial recessive IFN-γR1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds.
    Sologuren I; Boisson-Dupuis S; Pestano J; Vincent QB; Fernández-Pérez L; Chapgier A; Cárdenes M; Feinberg J; García-Laorden MI; Picard C; Santiago E; Kong X; Jannière L; Colino E; Herrera-Ramos E; Francés A; Navarrete C; Blanche S; Faria E; Remiszewski P; Cordeiro A; Freeman A; Holland S; Abarca K; Valerón-Lemaur M; Gonçalo-Marques J; Silveira L; García-Castellano JM; Caminero J; Pérez-Arellano JL; Bustamante J; Abel L; Casanova JL; Rodríguez-Gallego C
    Hum Mol Genet; 2011 Apr; 20(8):1509-23. PubMed ID: 21266457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion.
    Dupuis S; Döffinger R; Picard C; Fieschi C; Altare F; Jouanguy E; Abel L; Casanova JL
    Immunol Rev; 2000 Dec; 178():129-37. PubMed ID: 11213797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.